TC BioPharm Limited Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Other income (Tables)

Other income (Tables)

12 Months Ended

Dec. 31, 2021

Schedule of other (expenses) income

Schedule of other (expenses) income

		Year ended December 31,				Year ended December 31,				Year ended December 31,
		2021				2020				2019
		£				£				£
Grant income			6,381				547,928				1,163,624
Other income			-				21,272				397,642
Other (expenses)/income			6,381				569,200				1,561,266